GENE ONLINE|News &
Opinion
Blog

Innovation
R&D
Novartis’ Chronic Myeloid Leukemia Drug Demonstrates Superior Results to Pfizer’s
2020-12-10
Trials & Approvals
ASH2020: VelosBio’s ROR1 Targeted Therapy Shines in Safety Trial
2020-12-09
R&D
ASH2020: New Studies Showcase Potential of CAR-T Therapy to Treat More Cancers
2020-12-07
Technology
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
Envafolimab, the First Subcutaneously Administered PD-L1 Antibody for HBV Enters Phase IIb Study
2020-12-07
Funding Drug Development
Genesis Bags $52M Series A to Employ AI for Drug Discovery and Development
2020-12-06
R&D Aging
Researchers Discover New Aging Gene Using Mesenchymal Stem Cells
2020-12-05
Trials & Approvals Pyruvate Kinase Deficiency
Agios Pharmaceuticals’ Lead Candidate Mitapivat Achieves Primary Endpoint in ACTIVATE Trial
2020-12-03
In-Depth
In Vivo Functional Screen, PerturbSeq Helps Understand the Complex Interplay of Autism Risk Genes
2020-12-01
Two South Korean Companies Look to Capture the Biosimilars Market Worth Billions
2020-12-01
R&D Depression
Biogen and Sage Therapeutics Ink Deal for Treating Depression
2020-11-29
Funding COVID-19
Ginkgo Receives $1.1B from the US Government to Fight Pandemics
2020-11-29
Trials & Approvals
Ascentage Pharma’s Bcl-2 Inhibitor Enters Clinical Trials in Europe
2020-11-28
Trials & Approvals
FDA Requests Additional Info for Liquidia’s Pulmonary Arterial Hypertension Treatment
2020-11-27
Manufacturing
RESILIENCE Launches with an Aim to Overcome Limitations of Traditional Manufacturing
2020-11-25
1 … 35 36 37 38 39 … 58
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top